Clinical Trial Update: Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating XL784 in patients with albuminuria due to diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Diabetic Nephropathy

Drugs mentioned

• XL784

Snippet

Sponsor: Symphony Evolution, Inc. | Conditions: Albuminuria, Diabetic Nephropathy | Phase 2 | Status: COMPLETED